US6852496B1
(en)
*
|
1997-08-12 |
2005-02-08 |
Oregon Health And Science University |
Methods of screening for agents that promote nerve cell growth
|
US5968921A
(en)
*
|
1997-10-24 |
1999-10-19 |
Orgegon Health Sciences University |
Compositions and methods for promoting nerve regeneration
|
AU764603B2
(en)
|
1998-07-17 |
2003-08-21 |
United States Of America, Represented By The Secretary, Department Of Health And Human Services, The |
Water-soluble drugs and methods for their production
|
US6747055B1
(en)
*
|
1998-07-17 |
2004-06-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water-soluble drugs and methods for their production
|
MXPA01005641A
(es)
*
|
1998-12-07 |
2003-07-14 |
Ecosmart Technologies Inc |
Metodo y composicion para el tratamiento de cancer usando aceites vegetales esenciales naturales.
|
AU9254801A
(en)
*
|
2000-07-28 |
2002-02-13 |
Sloan Kettering Inst Cancer |
Methods for treating cell proliferative disorders and viral infections
|
CN1473055A
(zh)
|
2000-11-02 |
2004-02-04 |
˹¡-�����ְ�֢�о��� |
通过使用hsp90抑制剂提高细胞毒剂效力的方法
|
KR100850727B1
(ko)
*
|
2000-11-02 |
2008-08-06 |
슬로안-케테링인스티튜트퍼캔서리서치 |
에이치에스피90에 결합하기 위한 소분자 조성물
|
EP1423080A4
(de)
*
|
2001-03-01 |
2009-06-03 |
Conforma Therapeutics Corp |
Verfahren zur behandlung genetisch definierter proliferativer störungen mit hsp90-hemmern
|
US7825094B2
(en)
*
|
2001-05-23 |
2010-11-02 |
Sloan-Kettering Institute For Cancer Research |
Method of treatment for cancers associated with elevated HER 2 levels
|
US20090197852A9
(en)
*
|
2001-08-06 |
2009-08-06 |
Johnson Robert G Jr |
Method of treating breast cancer using 17-AAG or 17-AG or a prodrug of either in combination with a HER2 inhibitor
|
US6872715B2
(en)
|
2001-08-06 |
2005-03-29 |
Kosan Biosciences, Inc. |
Benzoquinone ansamycins
|
EP1923061A1
(de)
|
2001-09-24 |
2008-05-21 |
Conforma Therapeutic Corporation |
Verfahren zur Herstellung eines 17-Allyl-amino-Geldanamycins (17-AAG) und anderer Ansamycine
|
ATE387198T1
(de)
*
|
2001-09-24 |
2008-03-15 |
Conforma Therapeutic Corp |
Verfahren zur herstellung von 17-allyl-amino- geldanamycin (17-aag) und anderer ansamycine
|
US7261875B2
(en)
|
2001-12-21 |
2007-08-28 |
Board Of Regents, The University Of Texas System |
Dendritic poly (amino acid) carriers and methods of use
|
WO2003066005A2
(en)
*
|
2002-02-08 |
2003-08-14 |
Conforma Therapeutics Corporation |
Ansamycins having improved pharmacological and biological properties
|
WO2003086381A1
(en)
*
|
2002-04-10 |
2003-10-23 |
Conforma Therapeutics Corporation |
Ansamycin formulations and methods for producing and using same
|
US20060148776A1
(en)
*
|
2003-03-13 |
2006-07-06 |
Conforma Therapeutics Corporation |
Drug formulations having long and medium chain triglycerides
|
US20050020556A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
|
US20050054625A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors
|
US20050020534A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites
|
US20050054589A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics
|
US20050026893A1
(en)
*
|
2003-05-30 |
2005-02-03 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants
|
US20050020557A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors
|
US7691838B2
(en)
*
|
2003-05-30 |
2010-04-06 |
Kosan Biosciences Incorporated |
Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
|
US7241754B2
(en)
*
|
2003-06-13 |
2007-07-10 |
Kosan Biosciences, Inc. |
2-Desmethyl ansamycin compounds
|
CN100404029C
(zh)
*
|
2003-09-25 |
2008-07-23 |
中国医学科学院医药生物技术研究所 |
格尔德霉素(c-3559)在制备疱疹病毒生殖道感染药物中的应用
|
US6875863B1
(en)
|
2003-11-12 |
2005-04-05 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
US6855705B1
(en)
|
2003-11-12 |
2005-02-15 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
US6887993B1
(en)
|
2003-11-12 |
2005-05-03 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
CA2545457A1
(en)
|
2003-11-12 |
2005-06-23 |
Kosan Biosciences, Inc. |
11-o-methylgeldanamycin compounds
|
US20060019941A1
(en)
*
|
2003-12-23 |
2006-01-26 |
Infinity Pharmaceuticals, Inc. |
Analogs of benzoquinone-containing ansamycins and methods of use thereof
|
KR101154351B1
(ko)
|
2003-12-23 |
2012-06-15 |
인피니티 디스커버리, 인코포레이티드 |
암 치료를 위한 벤조퀴논-함유 안사마이신의 유사체
|
WO2005072766A2
(en)
*
|
2004-01-27 |
2005-08-11 |
Boys Town National Research Hospital |
Peptides that bind to hsp90 proteins
|
WO2006034147A2
(en)
*
|
2004-09-16 |
2006-03-30 |
Abraxis Bioscience, Inc. |
Compositions and methods for the preparation and administration of poorly water soluble drugs
|
US20060067953A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Conforma Therapeutics Corporation |
Oral pharmaceutical formulations and methods for producing and using same
|
CA2602257A1
(en)
*
|
2005-03-30 |
2006-10-05 |
Conforma Therapeutics Corporation |
Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
|
BRPI0608661A2
(pt)
*
|
2005-04-07 |
2010-01-19 |
Conforma Therapeutics Corp |
formulaÇço farmacÊutica, uso de formulaÇço farmacÊutica, e, mÉtodo de preparaÇço de uma formulaÇço farmacÊutica
|
US20060252740A1
(en)
*
|
2005-04-29 |
2006-11-09 |
Johnson Robert G Jr |
Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either in combination with a proteasome inhibitor
|
CN101175489A
(zh)
*
|
2005-04-29 |
2008-05-07 |
高山生物科学股份有限公司 |
用17-aag或17-ag或其前药治疗多发性骨髓瘤的方法
|
US20080032719A1
(en)
*
|
2005-10-01 |
2008-02-07 |
Outland Research, Llc |
Centralized establishment-based tracking and messaging service
|
WO2007002093A2
(en)
*
|
2005-06-21 |
2007-01-04 |
Infinity Discovery, Inc. |
Ansamycin formulations and methods of use thereof
|
WO2007035963A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Conforma Therapeutics Corporation |
Anti-tumor methods using multi drug resistance independent synthetic hsp90 inhibitors
|
WO2007064926A2
(en)
*
|
2005-12-01 |
2007-06-07 |
Conforma Therapeutics Corporation |
Compositions containing ansamycin
|
JP2010500047A
(ja)
|
2006-08-15 |
2010-01-07 |
エージェンシー フォー サイエンス,テクノロジー アンド リサーチ |
間葉系幹細胞馴化培地
|
PE20081506A1
(es)
*
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
Formulaciones de ansamicina
|
JP2010516282A
(ja)
*
|
2007-01-26 |
2010-05-20 |
コーサン バイオサイエンシーズ, インコーポレイテッド |
工学的生合成によるマクロラクタム
|
AU2008240153B2
(en)
*
|
2007-04-12 |
2013-01-31 |
Joyant Pharmaceuticals, Inc. |
SMAC mimetic dimers and trimers useful as anti-cancer agents
|
US20080255080A1
(en)
*
|
2007-04-12 |
2008-10-16 |
Wright James L |
Hydroquinone Ansamycin Formulations
|
JP2011501731A
(ja)
*
|
2007-09-10 |
2011-01-13 |
ユニバーシティ オブ マサチューセッツ |
ミトコンドリア標的化抗腫瘍剤
|
WO2009086170A1
(en)
*
|
2007-12-21 |
2009-07-09 |
Joyant Pharmaceuticals, Inc. |
Diazonamide analogs with improved solubility
|
KR101640381B1
(ko)
|
2008-02-22 |
2016-07-18 |
에이전시 포 사이언스, 테크놀로지 앤드 리서치 |
중간엽 줄기세포 입자
|
US8716018B2
(en)
|
2008-03-17 |
2014-05-06 |
Agency For Science, Technology And Research |
Microcarriers for stem cell culture
|
WO2009134938A1
(en)
*
|
2008-04-29 |
2009-11-05 |
Joyant Pharmaceuticals, Inc. |
Indoline anti-cancer agents
|
US8153619B2
(en)
*
|
2008-05-22 |
2012-04-10 |
Joyant Pharmaceuticals, Inc. |
Diazonamide analogs
|
WO2010045442A1
(en)
|
2008-10-15 |
2010-04-22 |
Infinity Discovery, Inc. |
Ansamycin hydroquinone compositions
|
JPWO2011040421A1
(ja)
|
2009-09-29 |
2013-02-28 |
武田薬品工業株式会社 |
スクリーニング方法
|
JP5529282B2
(ja)
|
2009-10-28 |
2014-06-25 |
ジョイアント ファーマスーティカルズ、インク. |
二量体Smac模倣薬
|
WO2011053257A2
(en)
|
2009-11-02 |
2011-05-05 |
Agency For Science, Technology And Research (A*Star) |
Methods of monitoring cellular states
|
SG183579A1
(en)
|
2011-02-11 |
2012-09-27 |
Agency Science Tech & Res |
Methods of detecting therapeutic exosomes
|
SG194223A1
(en)
|
2011-04-22 |
2013-11-29 |
Joyant Pharmaceuticals Inc |
Diazonamide analogs
|
EP3795694A3
(de)
|
2012-10-02 |
2021-06-23 |
The General Hospital Corporation d/b/a Massachusetts General Hospital |
Verfahren für mit dem dna-erfassungspfad assoziierten leiden
|
WO2015013581A1
(en)
|
2013-07-26 |
2015-01-29 |
Update Pharma Inc. |
Combinatorial methods to improve the therapeutic benefit of bisantrene
|
WO2015140005A1
(en)
|
2014-03-19 |
2015-09-24 |
Ifom Fondazione Istituto Firc Di Oncologia Molecolare |
Method of generation of pluripotent cells
|
WO2018070939A1
(en)
|
2016-10-12 |
2018-04-19 |
Agency For Science, Technology And Research |
Method for lyophilising an exosome
|